GlassScriptPhysician profile
Shailaja Gaddam
NPI 1316933971
$809.49
in general payments reported to CMS, 2019-2025
8 companies · $341 in 2025
The $341 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.55 · 2020: $36.67 · 2022: $35.75 · 2023: $107 · 2024: $227 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $555.45 | 2022-2025 | Ingrezza, Ongentys |
| Novartis Pharmaceuticals Corporation | $85.01 | 2019-2020 | |
| Abbvie INC. | $51.86 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $38.55 | 2025 | Dysport |
| Ucb, INC. | $28.55 | 2024 | Fintepla |
| Livanova USA, INC. | $25.52 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Mdd US Operations, LLC | $14.21 | 2019 | |
| Corium, LLC | $10.34 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shailaja Gaddam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.